Tower Research Capital LLC (TRC) - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 143 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,767
-66.1%
1,201
-61.5%
0.00%
-66.7%
Q2 2023$81,858
+166957.1%
3,122
+64.3%
0.00%
+50.0%
Q1 2023$49
-83.1%
1,900
-83.0%
0.00%
-83.3%
Q4 2022$290
-99.6%
11,146
+330.3%
0.01%
+1100.0%
Q3 2022$74,000
-78.6%
2,590
-81.6%
0.00%
-87.5%
Q2 2022$346,000
-0.3%
14,083
+128.7%
0.01%
+166.7%
Q1 2022$347,000
-0.6%
6,158
+9.3%
0.00%
-50.0%
Q4 2021$349,000
+47.3%
5,633
+50.9%
0.01%0.0%
Q3 2021$237,000
-35.6%
3,732
-16.3%
0.01%
-40.0%
Q2 2021$368,000
+503.3%
4,458
+437.1%
0.01%
+900.0%
Q1 2021$61,000
-11.6%
830
-12.8%
0.00%
-50.0%
Q4 2020$69,000
-86.6%
952
-91.2%
0.00%
-66.7%
Q3 2020$516,000
+416.0%
10,815
+356.3%
0.01%
+50.0%
Q2 2020$100,000
+354.5%
2,370
+133.7%
0.00%
+100.0%
Q3 2019$22,0001,0140.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 5,831,307$480,558,00031.49%
Consonance Capital Management LP 1,199,339$98,838,00011.90%
Boxer Capital, LLC 2,075,905$171,075,0006.04%
Perceptive Advisors 9,699,824$799,362,0005.19%
Orbimed Advisors 6,044,266$498,108,0005.04%
Samsara BioCapital, LLC 169,852$13,998,0001.73%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,375,775$113,378,0001.50%
SPHERA FUNDS MANAGEMENT LTD. 195,117$16,080,0001.09%
Artal Group S.A. 500,000$41,205,0000.84%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 558,574$46,032,0000.82%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders